HR 1076
118th Congress
House
Government Operations and Politics
Congressional oversight
Drug trafficking and controlled substances
Fraud offenses and financial crimes
Government studies and investigations
Internet, web applications, social media
Smuggling and trafficking
Preventing the Financing of Illegal Synthetic Drugs Act
Introduced: February 17, 2023
Introduced by:
De La Cruz, Monica
Republican
· Texas
See on congress.gov
Everywhere this bill has been
25 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 13, 2024
Became Public Law No: 118-79.
Sep 13, 2024
Signed by President.
Sep 11, 2024
Presented to President.
Jul 24, 2024
Message on Senate action sent to the House.
Jul 23, 2024
Passed Senate without amendment by Unanimous Consent. (consideration: CR S5319; text: CR S5319)
Jul 23, 2024
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Jul 23, 2024
Senate Committee on Banking, Housing, and Urban Affairs discharged by Unanimous Consent.
May 30, 2023
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
May 22, 2023
Placed on the Union Calendar, Calendar No. 55.
May 22, 2023
Committee on Energy and Commerce discharged.
May 22, 2023
Committee on the Judiciary discharged.
May 22, 2023
Reported (Amended) by the Committee on Financial Services. H. Rept. 118-75, Part I.
May 22, 2023
DEBATE - The House proceeded with forty minutes of debate on H.R. 1076.
May 22, 2023
Motion to reconsider laid on the table Agreed to without objection.
May 22, 2023
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
May 22, 2023
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
May 22, 2023
Considered as unfinished business. (consideration: CR H2483)
May 22, 2023
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
May 22, 2023
Considered under suspension of the rules. (consideration: CR H2469-2471)
May 22, 2023
Mr. Luetkemeyer moved to suspend the rules and pass the bill, as amended.
Feb 28, 2023
Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
Feb 28, 2023
Committee Consideration and Mark-up Session Held.
Feb 24, 2023
Referred to the Subcommittee on Health.
Feb 17, 2023
Referred to the Committee on Financial Services, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 17, 2023
Introduced in House
Votes taken on this bill
1
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| May 22, 2023 | House · vote #228 | On Motion to Suspend the Rules and Pass, as Amended | Passed | 402–2 | See who voted → |
Plain-English summary
Preventing the Financing of Illegal Synthetic Drugs Act
This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.
What's happening now
Became Public Law No: 118-79.